Fact CheckerSign in

NCT05954637Completed

Correlation of Structure and Function in Glaucoma

Source: ClinicalTrials.gov · Last updated 2 Dec 2025

Brief summary (registry, in English)

The aim of the study is to correlate structure and function in patients with glaucoma. To this end, a cross-sectional study unsing perimetry and optical coherence tomography is performed.

Status (registry)
Completed
Study type
Observational
Enrollment
60 (actual)
First submitted
10 Jul 2023
Start date
1 Jul 2023
Primary completion date
31 Dec 2024
Lead sponsor
Vienna Hospital Association
Diseases
Glaucoma
NCT number
NCT05954637

What you commit to

  • Study type: Observational
  • Participants enrolled: 60
  • From 1 Jul 2023 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Intraocular surgery 1 month prior to study entry

Other illness

  • Diabetes
  • Systemic or ocular disease, excluding glaucoma, which the investigator believes could affect the test results

Age

  • Age \< 18 years

Other

  • Pregnancy
  • Hypertensive retinopathy
  • Smoking
  • Insufficient quality of the optical coherence tomography imaging
  • Insufficient cooperation during examinations or measurements

Who the study is looking for

  • \- Diagnosis of glaucomatous optic neuropathy

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Ophthalmology, Clinic Hietzing, Vienna Healthcare Group
Coordinator of this site? Confirm its status
ViennaAustriaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.